COMPASSION RESPONSE NETWORK

Main Index --- Treatments Index --- Circulars Index

COMPASSION RESPONSE NETWORK CIRCULAR No 20

Planning Further Alternative Treatment Projects

The very first comparative assessment of a trial of an alternative treatment for HIV/AIDS was conducted in Kinshasa, Democratic Republic of Congo during 2004. The treatment selected was Imusil, a silver tetroxide compound. The final blood tests were taken in November 2004, and in the following months the full results of the six-months treatment and testing trial were published. They can be viewed at our CRN website under the section in the main index for Kinshasa Imusil Project Results.

The Kinshasa Imusil Project was “successful” in the sense that Compassion Response Network has now successfully completed its first alternative treatments project on a shoe-string budget, and we have remained independent facilitators of the trial, letting the published results speak for themselves.

Our goal is to trial at least a dozen alternative treatments each trial involving three HIV/AIDS patients, receiving the alternative treatment for six months, and receiving two-monthly blood tests for viral load count (bDNA), immunity cell count (CD4) and full blood count (white corpuscles, red corpuscles and platelets). Comprehensive medical checkups would be provided every two months. Several other blood tests useful to study HIV/AIDS patients would be provided (ferritin, urea, creatinine, liver function tests). Various other costs would need to be met to complete each trial, including food, transport, phone, courier delivery of products, financial support for doctors and nursing volunteers.

We had found it exceedingly difficult to fund our first project, raising our money through donations from the general public. All directors of CRN and project facilitators in Africa work voluntarily for no pay and we conduct each trial on the slimmest of shoe-string budgets. Even so, it took until March 2005 for CRN to fully pay off all commitments relating to the Kinshasa Imusil project. We were anxious to commence a second trial, so to start our comparative survey eventually to include trials on more than a dozen alternative treatments, and publishing the results. Such a published comparative survey will then provide the general public with an international, scientific, independent comparative assessment of these several treatments for HIV/AIDS. Once such a record is established, then we will have set in motion activity for broad compassionate trialling of treatments for HIV/AIDS on a very large scale and sidestepping the expensive and bureaucratically daunting procedures endorsed by the national health associations and international drug corporations. To our knowledge, no other group has accepted the challenge of facilitating such trials on a dozen alternative treatments for HIV/AIDS, and publishing the results in a comparative survey. And until that is done by a truly independent, international organisation, how can a member of the general public gain true information to compare the value of alternative treatments for HIV/AIDS, without having to trust the often inflated claims of promoters and product producers?

And so despite once again, having to work from a point of having no accumulated funds, we were eager to move on towards planning a second African trial, confident in our faith that when these plans were presented to the public, the public would open their hearts and help finance these further projects through their donations.

Kinshasa Pure Colloidal Silver + Oxyrich Project

On 15/March/2005, the Inner Planning Circle of CRN passed the following resolution;

That the second African alternative treatment trial use absolutely pure colloidal silver + Oxyrich, and it shall be held in Kinshasa. We will treat three patients over 6 months, providing full blood and medical tests, as with previous planned trials

Compassion Response Network will be supplying 2 ½ litres of pure colloidal silver + 1 litre of Oxyrich, purchased from Australian distributor Karen Taranto of Vital Breath ph (613) 5237 7997, postal Karen Taranto 8 McLenon St, Appollo Bay 3233, Australia.

This will be sufficient product to supply three patients each with treatment over 6 months each, each receiving 5 mls pure colloidal silver, and 2 mls Oxyrich daily.

The colloidal silver is given early in the morning before eating or drinking so the mouth will be dry and will adsorb the colloid very well. If early in the morning is too difficult to arrange, give some other time of day after the patient has not drunk for several hours. 5mls of pure colloidal silver is placed under the tongue with a glass eye-dropper. The patient holds it there for a minute and then may swallow. At least five minutes after receiving the colloidal silver, the patient has a glass of water with 2mls of Oxyrich placed in the water and stirred.

Colloidal silver particles, because of their positive charge, are repelled by the highly acidic stomach and intestinal lining, which therefore do not admit such positively charged particles to be adsorbed into the blood stream. But in the mouth and throat, the Ph balance is definitely alkaline, and under such situations, the positively charged silver colloid is rapidly adsorbed, that is, attracted and assimilated by the negatively charged mineral elements in the blood. The adsorption is greatest when the mouth is driest.

Oxyrich, in contrast, is most readily adsorbed into the blood in the stomach. Thus Oxyrich in water is drunk and directly goes to the stomach where it is adsorbed.

Much confusion exists between home-made colloidal silver and pure colloidal silver. They are in fact quite different products, with very different healing qualities.

Electro-colloidal silver was produced in very fine and pure quality through the major research universities of the 1950's. The university had access to highly sophisticated machinery, including cyclotrons valued at millions of dollars. It was this pure colloidal silver that was used to provide the amazing test results described by Dr Robert Becker (The Body Electric and Cross Currents) and other university researchers of the 1960's.

In reaction to the high cost of colloidal silver, in the 1980's a gadget was designed that would produce "home-made colloidal silver". The gadget was small, and would convert mains power to a direct current voltage of around 24 volts, which was then used with two pure silver electrodes to produce batches of colloidal silver. This technique would use only a small, cheap portable device, and so facilitated the making of colloidal silver in the home. Hence the reference to it as "home-made colloidal silver".

Home-made colloidal silver makers were promoted vigorously in the 1990's for both humanitarian and greedy commercial reasons. They used the exceptional scientific results gained through use of pure colloidal silver, to promote the home-made colloidal silver makers, even though the "home-made" product was clearly inferior. If well made, the "home-made" product still had an observable effect when treating infectious diseases.

The pure colloidal silver purchased from Vital Breath is a product that is as pure and effective as electro-colloidal silver produced in the universities in the 1950’s It is made from pure water filtered many times by scientific procedures. The colloid size is more than ten times finer than the home-made product, and is therefore much more effective in treating infectious diseases. In contrast to the 1950’s however this pure and fine product is now cheap to mass produce.

Our dosage requirements of 5mls daily lies well within the 20mls limit, that would be required to exceed the NHMRC (Australian regulator) daily consumption limit for silver.

Pure Colloidal Silver is made from exceptionally purified water, and uses modern technology in its preparation. It therefore has a purity that is scientifically verified as being only pure silver colloid. The pure colloid is of sufficiently small particle size to easily pass through cell membranes, and may be regarded as a constituent of the blood plasma, that is it may be regarded as a basic nutrition element, unable to congest and toxify the body.

Simultaneous administration of an oxygenation agent several times increases the effectiveness of the pure colloidal silver. Oxyrich provides a much more stable supply of oxygen than other forms of oxygen therapy, such as hydrogen peroxide or ozone. Oxyrich has one of the highest concentrations of bio available stabilised oxygen available today. It is non-chemically formulated (no mixing of potentially toxic chemicals), colorless, non-toxic, hypo allergenic, and completely safe to use as directed.

The oxygen in Oxyrich is a powerful topical and internal bactericide, fungicide and viricide. Tests show that the powerful oxygen present in Oxyrich renders most pathogenic anaerobic organisms harmless after direct application.

Kinshasa Pure Colloidal Silver + Oxyrich Budget

Though having few funds available, our Inner Planning Circle was eager to commence a second trial as soon as possible. On 20/May/05, after much planning and discussion, we agreed to a resolution to fund the pure colloidal silver + oxyrich project as follows;

That CRN commits to seek funds of A$7,000.00 for 6 months trials and blood testing of three HIV/AIDS patients in Kinshasa receiving Pure Colloidal Silver + Oxyrich treatment. CRN further approves expenditure of the above mentioned A$7,000 for the costs for the Kinshasa Pure Colloidal Silver + Oxyrich trials in accordance with the costings prepared by David and Albert and submitted on 14/May/05 with this proposal. These estimated costings for various items of the Kinshasa Pure Colloidal Silver + Oxyrich trials shall be attached with the minutes.

Details of the proposed Kinshasa budget are as follows;
a) Australian proposed expenditure:

b) Kinshasa proposed expenditure

On May/2005 exchange rates, the Kinshasa expenditure of US$4,215 equates to about A$(4,215/.75) = A$5,620. We are therefore looking at a total project expenditure estimate of A$1,380 + A$5,620 = A$7,000.00

By early May, the CRN fund had accumulated about A$1,100 to go towards this project. Expenditure on this project so far has included arranging pre-treatment triple profile blood tests (bDNA + CD4 + FBC) for the two men and one woman selected for the trial (results will be provided in next CRN circular), purchase of pure colloidal silver + oxyrich from Vital Breath (for A$215 + A$23 freight), plus purchase of ferrous sulphate + folic acid supplements. At the time of release of this circular, the amount of money remaining in the CRN fund, is US$172 held in Kinshasa and A$321.30 held in Perth. There remains a further about A$6,400 = about US$4,800 still to raise to fully fund the Kinshasa project. The group in Kinshasa are eager to proceed and so we are proceeding as fast as our limited funds available permit.

Tanzanian Trial

It would seem to us a miracle if we are able to raise enough money to fully fund the Kinshasa trial. And yet we have a strong prayer group, and have a faith in God’s provision to true need. And CRN could definitely not afford expenditure on other projects until the Kinshasa project has been fully funded.

We have many coworker contacts throughout Africa. One of these is Shadrack Kavalambi, based in Dar-es-Salaam in Tanzania. For over a year Shadrack had been discussing with us the possibility of trialling glyconutritional supplements on three patients in Dar-es-Salaam. Glyconutritionals are a nutritional treatment that have provided excellent results of the improvement for the immunity system for HIV/AIDS patients taking it in India and elsewhere. But with all our funds being directed towards funding the Kinshasa pure colloidal silver + oxyrich project, there was clearly nothing left over for a second African project at this time.

But from subtler dimensions, arrangements were happening which would set us in a completely new direction. Two months ago in mid-April, just a week before the Wesak Full Moon, I received an email from Shadrack, expressing his concern for two of the adult children of his late brother; both had advanced AIDS. 36-year-old Bennett was in a particularly desperate situation. A recent immunity test showed a CD4 reading of just 8. A healthy immune system has a CD4 reading of 500 to 600. A reading under 200 is very serious, and a patient so advanced is in grave danger of contacting a secondary infection which with an immunity count as low as 200, could be very serious. A CD4 reading of just 8 means the immunity system is virtually destroyed and no longer in any way effective. The mildest secondary infection could devastate the body and be lethal.

Inspired by the energies available at Wesak, our prayer group started to pray for Bennett. Our prayers were answered as two months later, Bennett remains alive and not having recent secondary infections of a serious nature. But how could we help Bennett in the longer term, perhaps helping him on the path to full recovery? Shadrack had been so invocative to trial glyconutritionals in Tanzania. CRN had no funds to buy and send anything over to Tanzania, so I personally donated A$820 to buy enough glyconutritionals in Australia to treat one person over 6 months, and A$255 to courier the product over to Dar-es-Salaam in Tanzania. I am on a disability pension, and this used up the last of my available credit. Our Inner Planning Circle then discussed the cost of sponsoring a trial in Dar-es-Salaam with glyconutritionals over 6 months, but involving just one patient to begin with. We formulated a shoe string budget for Dar-es-Salaam. Shadrack and Bennett’s family were eager to help all they could, even by sponsoring the pre-treatment blood test charges.

We therefore decided to go out on a limb and approve the following project budget for Dar-es-Salaam;

That CRN commits to seek funds of A$415 + US$1,400 for 6 months trials and blood testing of one HIV/AIDS patient in Dar-es-Salaam receiving Glyconutritional supplements. CRN further approves expenditure of the above mentioned A$415 +US$1,400 for the costs for the Glyconutritionals trial in accordance with the costings prepared by David and Shadrack and submitted on 15/June/05 with this proposal. These estimated costings for various items of the Dar-es-Salaam Glyconutritionals trials shall be attached with the minutes.

Estimated Costings for Dar-es-Salaam Trials

1) Expenditure in Australia

2) Expenditure in Tanzania

So we now have two projects to sponsor, one in Kinshasa with three patients and one in Dar-es-Salaam with one patient. Overall, we still have about A$7,000 to raise for these two projects. We proceed in trust of the calling of our heart, and faith that the public will respond.

The glyconutritionals package arrived in Dar-es-Salaam on Thursday 16/June/05, and by the time this CRN circular is being sent out, Bennett would have had all his pre-treatment blood tests and medical checkup and commenced his treatment.

We still lack by about A$500 enough to send the pure colloidal silver + oxyrich + bottles + measures + pharmaceutical supplements over to Kinshasa. We are praying that they can be delivered quickly so the Kinshasa trials can commence. The longer the delay, the greater the risk of one or more of the Kinshasa patients dying from secondary infections. And then there will be the remaining costs for the two African projects. We so desperately need donations of about a further A$7,000 in the very near future to fully sponsor these two projects. Otherwise, even now, one or both of these projects may need to be abandoned through lack of funds.

We are therefore launching a global public appeal to fully fund the Kinshasa and Dar-es-Salaam projects. Any donations received will be very gratefully accepted, and may be a significant factor in the success or failure of our present projects.

David Keane, Secretary,
Compassion Response Network

Top

Main Index --- Treatments Index --- Circulars Index